BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:NBI-1117570 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of NBI-1117570\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07288333-9469@assetmemo.bio
DTSTAMP:20261121T005651Z
DTSTART;VALUE=DATE:20270831
DTEND;VALUE=DATE:20270901
SUMMARY:NBI-1117570: Phase 2 readout est. (NCT07288333)
DESCRIPTION:NBI-1117570\, phase 2\, Schizophrenia.\nStudy: Evaluation of NB
 I-1117570 in Inpatient Adults With Schizophrenia\nEstimated primary comple
 tion: August 2027. This is a ClinicalTrials.gov estimate\, not a confirmed
  readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/nb
 i-1117570#upcoming-events\nRegistry record: https://clinicaltrials.gov/stu
 dy/NCT07288333
URL:https://assetmemo.bio/drug/nbi-1117570#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
